The fund is an exchange-traded fund (ETF) that seeks to meet its objective by having Corgi Strategies, LLC (the adviser) actively manage the fund and, under ordinary market conditions, invest at least 80% of its net assets (plus any borrowings for investment purposes) in a portfolio of companies materially involved in the development and deployment of technologies that collect, process, secure, analyze, and operationalize data for monitoring, risk management, security, compliance, and operational visibility across public and private environments. It is non-diversified.
Research context
Second Sight Medical Products appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Second Sight Medical Products, Inc is currently in a long term uptrend where the price is trading 0.2% above its 200 day moving average.
From a valuation standpoint, the stock is 87.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 167.4.
Second Sight Medical Products, Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.
Its net income has increased by 83.6% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 80.6% to $-1M since the same quarter in the previous year.
Based on the above factors, Second Sight Medical Products, Inc gets an overall score of 4/5.